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FOREWORD
The Life Sciences Research Office (LSRO), Federation
of American Societies for Experimental Biology (FASEB), provides
scientific assessments of topics in the biomedical sciences.
Reports are based upon comprehensive literature reviews and the
scientific opinions of knowledgeable investigators engaged in
work in specific areas of biology and medicine.
This technical report was developed for the National
Aeronautics and Space Administration (NASA) in accordance with
the provisions of Contract Number NASW 3924. It was prepared
and edited by John M. Talbot, M.D., Senior Medical Consultant
and Kenneth D. Fisher, Ph.D., Director, LSRO.
The LSRO acknowledges the contributions of the investi-
gators and consultants who assisted with this study. The report
reflects the opinions expressed by an ad hoc Working Group that
met at the Federation on March 5, 1985 and other consultants who
contributed to the study. The study participants reviewed a draft
of the report and their various viewpoints were incorporated into
the final report. The study participants and LSRO accept respon-
sibility for the accuracy of the report; however, the listing of
these individuals in Section VII does not imply that they specif-
ically endorse each study conclusion.
The report was reviewed and approved by the LSRO Advisory
Committee (which consists of representatives of each constituent
Society of FASEB) under authority delegated by the Executive Com-
mittee of the Federation Board. Upon completion of these review
procedures, the report was approved and transmitted to NASA by
the Executive Director, FASEB.
While this is a report of the Federation of American
Societies for Experimental Biology, it does not necessarily
reflect the opinion of each individual member of the FASEB
constituent Societies.
(date) ' Kenneth D. Fisher, Ph.D.
Director
Life Sciences Research Office
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SUMMARY
Decreases of red blood cell mass and plasma volume
have been observed consistently following manned space flights.
Losses of red cell mass by United States astronauts have averaged
10 to 15% (range: 2 to 21%). Based on postflight estimates of
total hemoglobin, Soviet cosmonauts engaged in space missions
lasting from 1 to 7 months have exhibited somewhat greater losses.
Restoration of red cell mass requires from 4 to 6 weeks following
return to Earth, regardless of the duration of space flight.
There are no reports suggesting that "astronaut anemia"
has impaired the health and performance of members of space crews
either inflight or postflight. Nevertheless, inflight illnesses,
injuries, or life support malfunctions could conceivably alter
cardiovascular-respiratory requirements such that a 10 to 15% dec-
rement in red cell mass could compromise crew safety and perform-
ance. Moreover, uncertainties exist as to the probable responses
of the hematopoietic system during possible future space missions
lasting a year or longer. Therefore, loss of red cell mass repre-
sents a contingent operational medical problem.
From the standpoint of the biologic effects of space
flight, the loss of red cell mass is a significant, predictable
response that is a model of the effects of space flight on human
proliferative tissues. Despite substantial investigation in the
United States and Soviet Union, the etiology, biologic mechanisms,
and potential operational significance of the loss of red cell
mass have not been adequately defined. Authorities in space medi-
cine, hematology, and related specialties regard the loss of red
cell mass as one of the end points of physiologic adaptation to
weightlessness. While the primary cause appears to be the influ-
ence of microgravity itself, the etiology is probably multifactor-
ial, including such influences as hypokinesis/hypodynamia, bone
demineralization and remodeling, muscle atrophy, altered hemo-
dynamics, and nutritional and metabolic disturbances. Othe^r
environmental influences such as hyperoxia, hypobaria, ionizing
radiation, toxic contaminants, and accelerative stresses of space
flight are probably not causal factors; however, their possible
influence remains to be established. Therefore, they should not
be dismissed at this time.
A majority of the members of the ad hoc Working Group
agreed that the loss of red blood cell mass in space flight and
the associated changes in red cell morphology observed to date
have been clinically and operationally insignificant. However,
these hematologlc phenomena are extremely important biologic
responses to space flight that deserve further scientific investi-
gation. Available information does not permit reliable extrapola-
tion of the probable course of erythrokinetics during future space
missions lasting a year or longer, nor can the possibility that
the loss of red cell mass could compromise the safety and effec-
tiveness of crew members be ruled out in flights complicated by
illness, injury, or life support equipment malfunction.
A lack of sufficient information on several essential
hematologic parameters emphasizes the need to expand data on red
cell losses by all feasible means.. Because of the continuing
obscurity of the biologic mechanisms involved, some members of
the LSRO ad hoc Working Group suggested that certain speculative
concepts should be considered even though supportive data are
currently limited. The research approaches (Chapters IV and V)
include basic, applied, and methodologic topics. They encompass
such fundamental questions as the utilization of erythropoietin
and oxygen at the molecular level in target organs, cellular inter-
actions, and blood-bone relationships, through possible vascular
and splenic dysfunctions, metabolic disturbances, and inhibitors
of erythropoiesis, to suggestions on methodology and models.
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I. INTRODUCTION
The Biomedical Research Program of the National Aeronau-
tics and Space Administration (NASA) addresses problems associated
with manned space flight. Since the inception of the U.S. and
U.S.S.R. space flight programs, the health status of crews has
been monitored and results have been the impetus for ground and
inflight research efforts. One aspect of these activities has
been the responses of the hematological system to space flight.
The most consistent finding observed in both the U.S.
program (Gemini, Apollo, Skylab, and Space Shuttle) and the
U.S.S.R. flights (Soyuz-Salyut) has been the reduction of plasma
volume (PV) and red blood cell mass (RCM). This latter phenomenon
has been referred to as "astronaut anemia," "space anemia," or
"anemia of space flight." RCM losses of 2 to 21% are accompanied
by decreases in hemoglobin mass (12-33%) and losses of 4-16% in PV
(Cogoli, 1981; Gazenko, 1983; Johnson, 1983; Kimzey, 1979). Eryth-
rocyte and hemoglobin concentrations in the blood remain constant,
suggesting that losses in mass are related to a complex series of
physiological responses to weightlessness, the most significant of
which may be PV loss. Evidence from prolonged flights by U.S.S.R.
cosmonauts (circa 175 days) shows losses of hemoglobin mass and no
inflight recovery from RCM losses. As with the results from NASA
studies of astronauts, postflight recovery is slow, taking up to
30 d or more (Johnson, 1983).
While there is no evidence that the reduction in RCM, in
numbers of circulating reticulocytes, and in PV affects performance
adversely, the confirmed occurrence is viewed as an issue requiring
investigation and explanation. The causes and mechanisms are poorly
understood despite considerable investigation over the past several
years. Although evidence is incomplete, most investigators consider
the anemia of space flight to be an endpoint of the processes of
adaptation to weightlessness. That is, it is a physiologic rather
than a pathologic response to microgravity and other aspects of
space flight just as polycythemia is a response to altitude.
Although there is general, but not universal, agreement
that the hematologic changes are physiologic, NASA continues to
maintain an active interest in the underlying causes, mechanisms,
and possible countermeasures because of the evolving goals of the
space station program and future considerations of interplanetary
travel. The ultimate configuration of the space station has not
been decided. However, as currently conceived, it will consist
of several modules designed to accommodate a crew of three to five
persons initially, and eight to twelve ultimately, in nominal mis-
sions lasting 90 d and operating in a low Earth orbit (500 km).
It will be supported logistically by the Shuttle Orbiter of the
Space Transportation System (STS). Future interplanetary missions
will be of considerably longer duration. Thus, questions regarding
changes in RCM require continued examination because of the
likelihood of flights of prolonged duration in the future.
As a part of the ongoing effort to review and evaluate
its research program in the life sciences, NASA requested that
the Life Sciences Research Office of the Federation of American
Societies for Experimental Biology undertake a review of its
research program and research needs in relation to RCM changes
during space flight. This report is based upon the opinions and
suggestions of an ad hoc Working Group of knowledgeable scientists
(see Section VII), whose members met at the Federation on March 5,
1985, and other experts who contributed additional data and
refinements.
II. OBJECTIVES AND SCOPE OF THE STUDY
The objectives of the LSRO study on loss of RCM in space
flight are to:
1. review extant knowledge on the subject;
2. determine if the RCM loss of red blood cell mass
requires additional research efforts;
3. identify significant gaps in knowledge;
4. formulate suggestions for possible research;
5. produce a documented report on the foregoing items
that can be used for program planning.
In accordance with NASA's guidance, the report focuses
not only on RCM losses that have occurred during space flights,
but also on its possible impact on the contemplated United States
Space Station, the Shuttle Program, and future long-term space
flights.
LSRO contacted a number of knowledgeable experts to deter-
mine contemporary scientific opinion on the current understanding
of the causes and mechanisms of RCM losses. Scientists were asked
to address issues related to extant knowledge and research needs.
Several of these expert scientists met to hear presentations by
NASA program staff, review scientific literature from both Soviet
and United States space programs, and to identify opportunities
for future research emphasis. The ad hoc Working Group discussions
focused on: (1) available human and animal studies from space
flight and its analogs; (2) hypotheses on causes and mechanisms;
(3) significance of the phenomenon and its relative importance
with respect to health and performance in space; (4) research gaps
and opportunities; and, (5) suggestions for research emphasis.
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III. BACKGROUND INFORMATION
Investigations on responses of the hematologic system to
the weightless environment of space flight have been conducted by
both Soviet and United States scientists since the initiation of
manned orbital flights. Preflight and postflight medical evalua-
tions were conducted to assess fitness of cosmonauts and astronauts
for various missions and to evaluate health status postflight. An
additional goal of these early efforts was to provide data on human
capabilities for prolonged space flights. As noted previously, the
basis of this review was the consistent observation of reduction
in RCM during ground-based simulations and space .flight as well as
the slow recovery of the hematologic system to preflight status.
Other hematologic changes observed include reduction of PV, hemo-
globin concentration, hematocrit, and percentage of reticulocytes.
Microspherocytosis may occur, but morphological changes in erythro-
cytes do occur. These latter changes are also related to decreased
RCM and increased osmotic fragility. Metabolic functions of red
blood cells are also modified in weightlessness.
A considerable body of data on RCM losses from animal
experiments and human observations has been collected by both
United States and Soviet investigators. In addition, several
ground-based experiments have been conducted to investigate pos-
sible causes and mechanisms associated with RCM and PV loss during
space flight. Most of these studies have been discussed in several
comprehensive reviews of the topic. For more detailed coverage,
readers should consult the reviews of Cogoli, 1981; Dunn et al.,
1981; Gazenko, 1983; Johnson, 1983; Kaplan, 1967; Kimzey, 1975,
1979; Larkin et al., 1972; and Tavassoli, 1982. This section of
the report presents an overview of background data and information.
A. PHYSIOLOGICAL STUDIES: 1927-1965
The effects of oxygen tension and ambient pressure on
hematopoiesis were the subject of a number of studies prior to the
manned space flight programs. For example, Campbell (1927) exposed
mice, rabbits, and monkeys to 400 mm Hg pure oxygen for 3 to 4 wk.
He observed reduction in hemoglobin content of up to 35% without
increases in the number of reticulocytes. While no changes in size
or types of erythrocytes were noted, as oxygen tension increased,
he found that blood color changed to that which was characteristic
of pernicious anemia. Boycott and Oakley (1933), in a series of
experiments with rats showed that suppression of erythropoiesis
was an adaptation to increased oxygen tensions just as stimula-
tion of erythropoietic activity is a response to decreased oxygen
tension. Anthony and Biedenkopf (1938) and Binet et al. (1939)
observed reduction in RCM and hemoglobin concentrations when
subjects breathed pure oxygen for several hours (time not other-
wise specified).
Reinhard et al. (1944), using subjects with sickle cell
anemia to avoid problems with pulmonary pathology, found reduced
reticulocyte counts and RCM losses in subjects breathing 80% oxy-
gen at one atmosphere pressure for periods of 8 to 20 d. Thus,
these and other investigations established that the oxygen concen-
tration in inspired air or gas mixtures did produce changes in
hemoglobin concentration and RCM.
Subsequent to World War II, with the advent of hyperbaric
medicine and interest in manned space flight as well as the devel-
opment of more critical instrumentation, the effects of oxygen,
pressure, and gravity on the hematopoietic system were studied in
greater detail. Early studies reported no adverse effects on the
hematologic system of human subjects exposed to 80% oxygen concen-
tration for 7 d at a chamber altitude of 10,000 ft (Michel et al.,
1960) and 100% oxygen concentration in a subject in a full pres-
sure suit for 72 h at an equivalent altitude of 35,000 ft (Hall
and Martin, 1960).
During the period 1958 to 1965, studies were conducted at
the U.S. Air Force School of Aviation Medicine, the U.S. Navy Air
Crew Equipment Laboratory, and Republic Aviation Corporation (Kaplan,
1967). Most investigations involved exposures of volunteer subjects
to increased oxygen concentrations at reduced atmospheric pressures
for various periods of time up to 30 d. Several typical parameters
of the hematologic system were measured during and after exposure.
In some experiments, reductions in hematocrit were noted; in others,
no changes were reported. Different patterns of reticulocytosis
and morphological changes in red and white blood cells were either
absent or present. However, despite the differences in data
obtained, no substantial evidence of irreversible and life threat-
ening effects on hematologic function or continuity of the hemato-
poietic system was found. These studies established that manned
space flight could be accomplished safely with increased oxygen
concentrations at reduced atmospheric pressures.
B. INFLIGHT STUDIES: 1965-1984
Hematologic evaluation of astronauts has been a part of
NASA's medical and research program since the Mercury missions.
Similarly, Soviet scientists have collected hematologic data in
their early space programs as well as the Soyuz and Salyut flights.
A synopsis of observations on RCM and PV losses of U.S. astronauts
is given in Table 1. In most cases, RCM and PV were measured by
intravenous administration of 125j-labeled human serum albumin and
51-Cr-tagged red blood cells. Changes were measured from data on
isotopic dilutions. Results of Soviet observations (Table 2)
express RCM as hemoglobin loss because no radioisotopes were admin-
istered and hemoglobin concentrations were measured spectrophoto-
metrically. It is obvious from the data in Tables 1 and 2 that
reduction in RCM and PV is a phenomenon associated with orbital
space flight.
Table 1. Changes In Red Blood Cell Mass and Plasma Volume Observed In U.S. Manned Space
Fl Ight Missions*
Mission
Gemini 4
5
7
Apol lo 7
8
9
14
15
16
17
Skylab 2
3
4
Apol lo-Soyuz
Duration
(days)
4
8
14
1 1
6
10
9
12
It
13
28
59
84
9
Number of Subjects
Studied
2
2
2
3
3
3
3
3
3
3
3
3
3
3
Mean Change
In RCM
(percent)
-12
-21
-14
-3
-2
-7
"'I
-10 1
-14 \
-11 J
-14
-12
-7
-7
Mean Change
In PV
(percent)
-9
-7
+ 11
-4
-9
-13
-16
-1 1
» Modified from presentations of Gogol I, 1981; Johnson, 1983; Klmzey, 1979; and,
TavassolI , 1982.
Table 2. Changes In Hemoglobin Mass Observed In Soviet Manned Space Flights*
Mission
Soyuz 14
Salyut 3
4
4
5
5
6
6
6
Durat Ion
(days)
15
16
30
63
18
49
96
140
175
Mean Change In Hemoglobin Mass**
(percent)
-12
-12
-27
-16
-14
-33
-24
-16
-18
* Modified from presentations from Gogol I, 1981 and Vorobyev et al., 1983.
** In most flights, data were collected on two cosmonauts.
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It should be noted that additional hematological studies
were also conducted along with measures of RCM and PV. For
example, data from the Gemini series established that mean cor-
puscular volume and red cell osmotic fragility were increased
while red cell membrane lipid content and phosphofructokinase
activity were decreased. Data collected from Apollo and Skylab
flights were variable and failed to confirm observations made
during Gemini flights. It is recognized that modifications of
cabin atmosphere (Gemini:100% oxygen at.258 mm Hg; Apollo:95 to
100% oxygen with 0-5% nitrogen first at 760 mm Hg up to launch,
then 100% oxygen at 258 mm Hg; Skylab:70% oxygen and 30% nitrogen
at 258 mm Hg) in the three series of flights affected the strict
comparison of data on hematologic changes.
Prior to and during the Apollo, Skylab, and Apollo-
Soyuz missions, a series of ground-based studies was conducted
with astronauts maintained in chambers where environmental condi-
tions were similar to those in the respective flight capsules for
identical durations. Some studies at the Brooks Air Force Base
chamber indicated that atmospheres of 100% oxygen at 258 mm Hg
produced RCM losses in 30 d, but nine analogous studies in this
series produced few significant changes in red blood cell physi-
ology or RCM reduction (Kimzey, 1979). The impact of these obser-
vations or hypotheses on causes and mechanisms is discussed in
Section D (p.11).
While the number of inflight animal studies has been
limited, their results are significant in terms of factors
causally related to RCM losses. Leon et al. (1978) found that red
blood cell lifespan of male pathogen-free Wistar rats flown 19.5 d
in Cosmos-782 was reduced 5.4% and hemolysis of red blood cells
was increased three-fold when compared to control animals kept in
a vivarium. Leon et al. (1978) acknowledged that other factors
may have contributed to these observations, but the major signif-
icant difference was the weightless state of inflight animals. In
experiments with pathogen-free male Wistar rats flown on Cosmos-
936 for 18.5 d, Leon et al. (1980) observed that hemolysis of red
blood cells was related only to weightlessness because little or
no hemolysis occurred in those rats which were exposed to weight-
lessness inflight but centrifuged to produce an artificial gravita-
tional field (1-G). These studies established that, in rats,
increased hemolysis in reduced or at zero gravity is the result
of weightlessness alone.
Because bone marrow can compensate for reduced red blood
cell lifespan by increased production (Crosby, 1981), RCM might be
expected to remain constant. But RCM decreased in rats held in
the weightless condition because of not only hemolysis but also,
probably, inhibition of erythropoiesis. Vacek et al. (1982) also
reported reduced hematopoietic responsiveness of marrow from space-
flown rats.
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In reviewing these studies and other data, Leon et al.
(1982) noted several similarities between decreased RCM in weight-
lessness and RCM decreases occurring in post-hypoxic polycythemia.
That is, both represent nonpathologic increased hemolysis; the hemo-
lysis occurs in normoxic conditions; and, both situations show
suppressed erythropoiesis relative to the previous condition. They
noted also, that in both conditions, while initiated by different
factors, the common factor is a relative excess of capacity to
deliver oxygen as compared to the oxygen need. Stated another
way, RCM losses are a physiological adaptation to weightlessness.
Recently, Leach and Johnson (1984) reported on hematologic
studies of four crew members on Spacelab 1 and six matched control
subjects who served as a ground-based control group. As expected,
hemoglobin concentration and hematocrit of the four Spacelab sub-
jects increased 22 h after exposure to weightlessness. On landing,
hematocrit, RCM, PV, and reticulocyte counts were reduced. How-
ever, while decreases in serum erythropoietin (epo) were noted
in all flight crew members, the reductions in epo levels were not
statistically significant. This lack of a significant reduction
in serum epo levels accompanied by a significant decrease in
reticulocyte number together with the progressive loss of RCM
during flight suggested to Leach and Johnson (1984) that inhibi-
tion of erythropoiesis was not the major or sole cause of RCM
loss.
C. GROUND-BASED EXPERIMENTS: 1965-1984
The reduction of RCM and PV, together with other hemato-
logical changes that occurred in the Gemini missions were reported
initially by Fischer et al. (1967). Their report and observations
had a major impact on hematologic studies conducted in support of
the Apollo and Skylab programs and influenced the scope and direc-
tion of Soviet studies of hematologic changes. The hypothesis
suggested from the Gemini data was that reductions in RCM and PV
were related to the hypobaric, hyperoxic atmosphere of the capsule
(Fischer et al., 1967).
As noted previously, ground-based studies conducted at
Brooks Air Force Base showed that exposures to atmospheres of 100%
oxygen at reduced pressures (258 mm Hg) did lead to increased hemol-
ysis and decreased RCM (Larkin et al., 1972). These investigators
exposed eight healthy, nonsmoking, male volunteers to 30 days of
100% oxygen at 258 mm Hg. At the conclusion of the exposure period
subjects were exposed to transverse gravitational forces (maximum
8.26 G) simulating the Gemini reentry profile. Using both the car-
bon monoxide dilution and the 51cr labeling methods, they found
significant decreases in RCM related to both reduced erythropoiesis
and increased hemolysis. Plasma hemoglobin levels were increased,
reticulocyte counts were reduced, and erythrocyte survival rates
were decreased. Upon return to normal atmospheres and pressures,
hematologic parameters of all subjects returned to preexposure
(normal) levels within 116 d.
Despite the clearcut results of these investigations,
subsequent ground-based chamber studies conducted in support of
the Apollo and Skylab programs were essentially inconclusive
(Kimzey, 1979). For example, a 60-d study of three astronauts in
the SMEAT (Skylab Medical Experiments Altitude Test) chamber found
no significant changes in erythrocyte physiology or circulating
RCM (Kimzey, 1979). These observations, taken together, added
credibility to the hypothesis that oxygen toxicity played a major
role in RCM losses. However, Skylab astronauts exposed to a 70%
oxygen and 30% nitrogen atmosphere at 258 mm Hg exhibited RCM
losses similar to those of astronauts in Gemini, Apollo, Soyuz,
and Salyut flights (Tables 1 and 2).
A number of investigators have established that prolonged
bed rest will result in reductions in hematopoiesis and RCM that
are analogous to those observed in crew personnel after orbital
flights (Balakhovskiy et al., 1980; Kiselev et al., 1975; Lamb
et al., 1964; Miller et al., 1965; Stevens et al., 1966). Upon
recovery from bed rest, subjects typically exhibit an increase in
reticulocyte counts. Recovery periods are also analogous to those
seen after space flight. These results suggest that bed rest is
an analog of the weightless state in that gravitational influence
is lessened and antiorthostatic hypokinesia induces a reduced rate
of hematopoiesis.
Leach and Rambaut (1977) noted an increased osmolality of
urine in Skylab astronauts. Leon and Fleming (1980) called atten-
tion to the hypothesis of Alexander et al. (1975) that prolonged
excretion of hypertonic urine would lead to increased destruction
of red blood cells. To investigate these phenomena, Leon and
Fleming (1980) studied red blood cell hemolysis, senescence, sur-
vival, and reticulocyte count in Sprague-Dawley male rats main-
tained on one-third normal water intake for 20 d. They observed
that urine osmolality decreased, reticulocytosis occurred, but red
blood cell survival was unchanged. They concluded that their data
did not support Alexander's hypothesis, but also noted" that..differ-
ences in methodology (random-labeling versus cohort-labeling)
might explain their results because both suppression of erythro-
poiesis and hemolysis of existing red blood cells were occurring
as a result of restriction of water and food intake. Despite the
observations on hemolysis of red blood cells in rats both in
ground-based and inflight studies, evidence for hemolysis of red
blood cells in astronauts and cosmonauts is lacking even though
decreased water intake, increased urine osmolality, and reticulo-
cytosis are typically observed. For example, Kiselev et al.
(1975), in a study of 21 subjects exposed to 30 days' bed rest and
six subjects exposed to 100 days' bed rest, found reduced erythro-
poiesis and hemoglobin mass as expected. However, they also
monitored nitrogen excretion and found normal values (14-17 g/d),
thus precluding the occurrence of a significant rise in tissue
degradation.
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In recent years, attention has been focused on factors
other than oxygen .toxicity and hemolysis as causes of RCM losses.
One such factor is the hormone erythropoietin. This hormone, pro-
duced in the kidney, is the circulating factor which stimulates
erythropoiesis. Dunn et al. (1983, 1984a) studied healthy males
exposed to horizontal or 6° head-down tilt bed rest for 7-d periods,
Their studies provided no data to support the concept that the
observed decrease in erythropoiesis was related to circulating
levels of epo. These results suggest further that the increases
in hematocrit following reduction in PV were not the stimulus for
suppressed erythropoiesis. Dunn et al. (1983) suggested that RCM
losses might be the result of direct alterations of or effects on
the bone marrow.
D. HYPOTHESES ON CAUSES AND MECHANISMS
Since the initiation of the Gemini Program and the con-
sistent finding of RCM losses in space flight crews, explanation
of the causes and mechanisms has involved a number of hypotheses.
In general, the evolution of hypotheses reflects chronologically
the accumulation of data on the phenomenon. Originally, the cause
of RCM changes was thought to be related to the environmental
factors encountered in the capsule, that is, hyperoxia, hypobaria,
and reduced gravity. Studies conducted in both the U.S. and
Soviet space programs led to refinements in factors related to
cabin environments. These, in turn, raised additional questions
about the influence of external factors and humoral responses to
space flight that might affect circulating RCM. Thus, several
discrete, but interrelated, hypotheses have been advanced to
explain the RCM losses occurring in space flight.
Each of the hypotheses has attempted to account for the
decreases in RCM by considering either reduction or suppression of
red blood cell production, increased destruction or loss of circu-
lating erythrocytes, or a combination of both. The major hypoth-
eses include the following:
1) Hyperoxia and Hypobaria. Data from animal and human
studies carried out before manned space flight had estab-
lished that increased oxygen tension induced hemolysis
and suppressed erythropoiesis. Similarly, hypobaria was
known to increase hematocrit and alter RCM. Because
cabin atmospheres in Gemini and early Apollo missions
were 100% oxygen at 258 mm Hg, hyperoxia and possibly
hypobaria were suggested as the primary cause of RCM
losses (Kimzey et al., 1975). However, subsequent data
from Skylab flights where cabin atmospheres were 70%
oxygen and 30% nitrogen at 258 mm Hg, and Soviet flights
where cabin atmosphere is air at 760 mm Hg suggest
hyperoxia and hypobaria are not the sole cause of RCM
losses.
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2) Hemolysis, Sequestration, and Hemorrhaging. While
originally suggested independently, these three factors
focus on loss or destruction of circulating red blood
cells rather than suppression of erythrocyte production.
Hemolysis was thought to have occurred along with short-
ened red cell survival times in the Gemini astronauts
(Fischer et al., 1967). Animal inflight experiments
which found increased hemolysis added support to this
hypothesis. However, little evidence of hemolysis or
shortened red blood cell lifespans has been gathered
from postflight examinations of astronauts. While nega-
tive nitrogen balances were evident in Skylab astronauts
(Whedon et al., 1977), suggesting increased tissue
destruction, these appear to be more closely related to
muscle atrophy-in the lower extremities rather than RCM
losses. Further, Soviet data suggest no negative
nitrogen balance in cosmonauts who do exhibit significant
decreases in RCM. There is no evidence of blood losses
in astronauts or cosmonauts that are sufficient to
account for the reductions in RCM observed inflight.
While evidence of gross hemolysis or hemorrhaging is
lacking, microhemorrhages in the pulmonary or upper body
circulation, capillary oozing, or splenic sequestration
as a result of flight acceleration or reduced gravitational
forces have been suggested as possible pathophysiological
responses which could contribute to red blood cell loss
and destruction, thus leading to reduced RCM.
3) Erythropoietic Suppression. Evidence for this hypoth-
esis is derived not only from reticulocyte studies and
marrow differential cell counts, but also from the obser-
vation that anemia occurs in the absence of abnormal
hemolysis. Reduction in reticulocyte counts is a con-
sistent finding in flight crew members who exhibit RCM
losses. More importantly, the reduction in RCM in the
absence of hemolysis suggests strongly that red blood
cell production is insufficient. Thus, it appears that
erythropoiesis is suppressed, inhibited, or interrupted
as a direct consequence of weightlessness. However,
evidence collected to date suggests that erythropoietic
suppression is not a direct consequence of dehydration
or levels of circulating epo, but rather, is related to
alterations within the bone marrow as a consequence of
weightlessness. Why this occurs is not fully understood.
In recent Shuttle missions (3-d duration), postflight
examination revealed no reduction in reticulocyte numbers
suggesting no bone marrow inhibition. But data from
earlier United States and the Soviet missions do show
reduction in reticulocyte numbers inflight. It should
be noted that despite this observation, no relationship
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between duration of mission and extent of RCM loss has
yet been established. If bone marrow inhibition occurs
early in the flight, it could contribute to the RCM
decrease. The relatively steady state of RCM in pro-
longed flights would then be related to the status of
the hematopoietic and circulatory systems as altered by
weightlessness. Data on other physiologic parameters
collected inflight do support the concept of bone marrow
inhibition. The observed inflight increased hemoglobin
concentration and decreased PV could suppress erythro-
poiesis if oxygen-hemoglobin dissociation curves and
blood flow rates remained the same, but these are
affected by blood C02 concentration, pH, and temperature,
Changes in blood pCC>2 and serum phosphorus inflight have
been suggested as possible contributing factors.
4) Nutrient Deficiencies. Lack of intake or mobiliza-
tion of body stores of iron, folate, vitamin 8^2. or
protein have been suggested as contributing factors in
RCM losses (see also p.17). The rapid onset of RCM
losses after launch and the lack of progressive decre-
ments in RCM with prolonged flights argue against this
hypothesis. However, Dunn et al. (1981) reanalyzed data
collected during the Skylab missions and found a highly
significant correlation between RCM loss and changes in
dietary intake, exercise performed, and lean body mass
(LBM). They postulated that RCM loss might be an adapta-
tion to loss of body weight which could be prevented by
techniques that maintain LBM or increase tissue oxygen
demands, e.g., exercise.
Other hypotheses which have been suggested include
decreases of water and/or food intake leading to produc-
tion of hypertonic urine and renal hemolysis, altered
functional capabilities of presenescent red blood cells
as a consequence of the observed morphological differ-
ences in reticulocyte and red cell shape and size, and
alteration of patterns of circulating hormones because
of zero gravity, resulting in cellular metabolic effects.
Deliberations of the ad hoc Working Group focused on an
assessment of the weight of evidence supporting or
refuting these several hypotheses. Results of these
discussions are reported in Chapter IV.
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IV. OBSERVATIONS OF THE LSRO AD HOC WORKING GROUP ON
RED BLOOD CELL MASS CHANGES
A. SIGNIFICANCE, ETIOLOGY, AND MECHANISMS OF LOSS
Significance
Opinion was unanimous that the losses of RCM observed in
manned space flights have apparently been clinically and function-
ally insignificant and reversible. However, a potential'of such
losses for physiologic impairment in certain postulated situations
cannot be ruled out by currently available information. Examples
of circumstances in which diminished RCM could become a compli-
cating factor might include inflight illness or injury, reduction
of breathing oxygen to marginal levels from system damage or mal-
function, repeated space flights without sufficient interval
recovery, and future missions of very long duration.
The success of the Skylab and Salyut-Soyuz series of mis-
sions suggests that RCM losses may not complicate spacecrew func-
tions on missions of long duration (arbitrarily defined as 1 mo or
longer). According to Gazenko (1983) ... "space flights lasting
up to 7 months do not lead to any qualitatively new biological
changes in the human organism." Nevertheless, certain Soviet data
suggest that, in some missions, the decrease of RCM exceeded the
approximately 10-15% decrease that has become generally recognized
as typical in United States experience. For example, Balakhovskiy
et al. (1980) reported that hemoglobin content of blood taken
postflight from cosmonauts who participated in missions lasting
between 1-2 mo declined to values 67-75% of base levels.
From the standpoint of the biologic effects of space
flight, the Working Group regarded the loss of RCM as highly sig-
nificant; it is a predictable response featuring measurable alter-
ations of marrow structures and functions in this rapidly repro-
ducing human tissue. Therefore, "space anemia" represents a model
of the effects of space flight on human proliferative tissues, and
successful investigation of the involved mechanisms should not
only help to decide the issue of its space medical relevance, but
also should yield valuable clues on biologic responses in other,
less rapidly proliferating tissues. On the basis of its apparent
clinical insignificance, some participants were of the opinion
that further studies of the phenomenon should not have a high
priority in NASA research. However, a majority of participants
were convinced that the subject of space-related loss of RCM
should be actively investigated until such time as its biological
and potential operational significance in long duration flights is
established.
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Etiology and Mechanisms
Most authorities in space medicine and related specialties
tend to view the loss of RCM as one of the end points of physiolog-
ical adaptation to weightlessness; hence, the primary cause is prob-
ably the influence of microgravity itself (Cogoli, 1981; Gazenko,
1983; Gazenko et al., 1981; Nicogossian and Parker, 1982; Yegorov,
1979, 1980). A possible scenario, based on published concepts of
a regulatory feedback system in red cell homeostasis (Erslev,
1971; Erslev and Caro, 1985; Fan et al., 1980; Thorling and
Erslev, 1968) might include the following sequence of physiologic
events:
Upon entry into weightlessness, the documented
headward shift of blood and tissue fluids takes
place and results in suppression of antidiuretic
hormone. This is followed by a rapid diuresis
and marked decline in PV, causing a dehydration
erythrocytosis. In turn, the erythrocytosis
causes suppression of epo production and/or
other processes until the RCM shrinks to a
level consistent with the hematocrit and blood
viscosity associated with the altered PV. This
condition prevails until return to Earth gravity,
when PV increases rapidly following thirst
quenching, blood and body fluids redistribute
to preflight patterns, and the resulting dilution
of the RCM reflects a reduced hematocrit and
anemia. After a few weeks postflight, acceler-
ated erythropoiesis restores the RCM to normal.
If such a sequence is logical, then it follows that the
loss in RCM mass is at least a biphasic process. Available data
indicate that RCM reductions can be observed in astronauts with 4
days' exposure to microgravity. Because red blood cell lifespan
is about 120 d, a 10% RCM loss would require at least 12 d with
complete cessation of erythropoiesis. But erythropoiesis is not
shut down completely as reticulocytes can be found in the circu-
lating blood and iron turnover has been demonstrated inflight.
Therefore, the RCM loss in the first 4 d must involve other pro-
cesses such as hemolysis, sequestration, and/or extravasation.
The subsequent decline and maintenance of reduced RCM to about 90%
of normal values appears to be a second phase of the physiological
adaptation process.
Further, the postflight recovery period appears to take
at least 30 d regardless of the length of the period of weight-
lessness. Reticulocytes do not appear to be numerous until 2 or 3
weeks postflight. This suggests that some physiological stimulus
or proliferative marrow modification must precede increased hemato-
poiesis postflight.
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Any hypothesis on etiology and mechanisms of RCM loss in
weightlessness and postflight recovery should account for these
observations from animal and human subjects.
The apparent protection of artificial gravity against
an approximately three-fold increase in random hemolysis in space-
flown rats shown by Leon et al. (1978, 1980) is impressive. These
results suggest that the excessive hemolysis results from a mechan-
ism activated by weightlessness. At the cellular level, experiments
with cell cultures in centrifuges, clinostats, and space flights
have shown that, in general, hypergravity promotes cell prolifera-
tion whereas microgravity has a depressing effect (Cogoli et al.,
1984).
Despite the evidence that exposure to microgravity
appears to be the prime cause of the reduced RCM in human subjects
(Johnson, 1983) and increased random hemolysis in space-flown rats
(Leon et al., 1978), members of the ad hoc Working Group believe
that the etiology is probably multifactorial. Some possible
impinging factors are listed in Table 3. Space medical special-
ists have tended to set aside some of the items in Table 3 as
being unlikely contributing factors, such as radiation exposure,
which has been within prescribed permissible levels, hyperoxia in
Soviet and American spacecraft in which cabin atmospheric PC>2 has
approximated sea level values, and endocrine changes sufficient
to suppress erythropoiesis (Gazenko et al., 1981; Johnson, 1983;
Leach and Rambaut, 1977; Yegorov, 1979, 1980). Hypodynamia and
hypokinesia are labeled "unavoidable" because, despite the phys-
ical activities of space flyers including programmed vigorous
exercises, the all-pervading microgravity relieves the body of
the constant neuromuscular and musculoskeletal effort required
for normal living on Earth.
Some members of the Working Group believe that nutri-
tional and metabolic aberrations during space flight could account
for the apparent hypoproliferative character of the anemia. For
instance, the presence of acanthocytes (echinocytes) in human
blood is known to reflect such conditions as starvation, hypo-
thyroidism, impaired ATP metabolism, and traumatic hemolysis.
In these circumstances, one would expect low levels of epo, low
reticulocyte counts, and anemia which could be physiologic in the
presence of reduced protein intake and/or decreased production of
thyroid hormones; or reduced total body oxygen requirements. In
part, such a rationale appears consistent with the hypodynamia and
hypokinesia, reduced food and fluid intakes, and negative nitrogen
balances that have been documented in space flight. Thus, the
reduction in RCM would reflect a decrease in oxygen consumption.
In addition, Soviet scientists reported minor reductions of mean
red cell volume on the first postflight day after long-term
flights (Ushakov et al., 1982). The occurrence of microcytosis
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Table 3.
RCM
Possible Contributing Factors in Space-related Loss of
• Unavoidable hypodynamia and
hypokinesia
• Alterations in structure
and/or function of the bone
marrow associated with bone
demineralization, remodeling,
and negative calcium balance
• Disturbances in intramed-
ullary integrity associated
with weightlessness
• Transient or intermittent
inflight disturbances of
nutrition and fluid balance
• Metabolic imbalances result-
ing in muscle atrophy and
negative nitrogen balance
• Capillary oozing of RBC dur-
ing accelerations of launch-
orbit and deorbit-reentry
• Endocrine shifts
• Unidentified circulating
inhibitors of erythro-
poiesis
• Transient hyperoxia dur-
ing EVA oxygen prebreath-
ing and EVA
• Toxic substances in the
breathing atmosphere
• Cardiovascular decondi-
tioning and altered
regional hemodynamics
• Fatigue and disturbed
biorhythms
• Unidentified space radia-
tions
• Disturbances in bio-
logical rhythms or the
"biological clock"
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as a component phenomenon of "space anemia" suggests a profound
alteration of erythropoiesis. However, more data are needed to
establish the occurrence of microcytosis as a result of space
flight. Data from United States and Soviet space flights do not
support a hypothesis of nutritional insufficiency as a cause of
decreased RCM; however, reductions in lean body mass correlate
significantly with decreased RCM (Dunn et al. , 1981; Johnson,
1983).
The effects of protein deprivation on epo production
and erythropoiesis were reviewed recently by Fried and Anagnostou
(1983). The sensitivity of the rate of synthesis of human epo to
protein intake was demonstrated by depressed urinary epo levels
and the reticulocyte response to phlebotomy after 8 d of consuming
a diet containing 17% of the Recommended Dietary Allowance (RDA)
for protein (Catchatourian et al., 1980). Rats consuming diets
with up to 60% of recommended protein content produced less epo
in response to hypoxia than controls fed normal diets (Fried and
Anagnostou, 1983). However, the protein-deprivation that has been
associated with anemia in human subjects has been severe; similarly,
in animal studies, protein-free diets or diets markedly deficient
in protein have apparently been required to produce significant
decrements in such erythropoietic parameters as burst-forming
units-erythroid (BFU-E) and colony-forming units-erythroid (CFU-E)
production and reductions in erythrocytic half-lives (Fried and
Anagnostou, 1983).
The reported normal plasma levels of key transport pro-
teins in the astronauts and lack of evidence of hypofunction of
the thyroid gland during space flight argue against the idea of
a nutritional and/or hormonal basis of etiology. Moreover, the
Skylab data on negative nitrogen balance represent the only pub-
lished data from carefully conducted inflight human metabolic
studies to date. This single set of data emphasizes a need for
an expanded data base in this area to address such questions as
uniformity of response among space flyers, temporal pattern of the
negative nitrogen balance, and its possible inflight reversibility
by available or potential countermeasures.
Disturbances of Target Organ Homeostasis
Information presented at the ad hoc Group meeting sug-
gests that most of the loss of RCM in spacecrew members studied
in Spacelab 1 occurred within 4 d after commencing orbital flight.
The evidence for a hypoproliferative bone marrow as a major ini-
tial factor in the indefinite prolongation of the reduced RCM
appeared convincing to the members of the Working Group. The
majority considered the hematopoietic marrow to be the site of
the unknown mechanisms that result in apparent suppression of
erythropoiesis during space flight.
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The marrow is a complex organ composed of the prolifer-
ative hemopoietic tissue and supporting stroma: scaffolding
and microcirculation that support and nurture the proliferating
tissues. The microcirculation is a unique, sinusoidal structure.
Normal erythropoiesis is dependent on the integrity of these
structures in the hematopoietic microenvironment. According to
Fried and Anagnostou (1983), proliferation and differentiation
of pluripotential stem cells depend on interactions with the cells
in the hematopoietic microenvironment and on the structural and
functional integrity of fixed stromal elements in the hemato-
poietic sites. Moreover, recent work has shown that, in certain
circumstances, processes involved in hematopoiesis and osteogen-
esis may interact such that failure in one step of differentia-
tion, development, and functioning of the cells of one system may
result in failure in the other (Vaughan, 1981).
Bone demineralization and negative calcium balance are
well documented responses to space flight (Anderson and Conn,
1983). Perhaps the demineralization may modify the milieu of
the marrow in such a way as to affect response to epo. Korzhuyev
reported that hemopoiesis is inhibited under the influence of dys-
trophic processes in bone (Balakhovskiy et al., 1980). However,
Balakhovskiy et al. (1980) noted that hemoglobin mass and reticu-
locyte counts decrease even after space flights of 2 weeks, when
... "no signs of dystrophic processes in bones have appeared."
Both stimulatory and depressant effects appear to result, in part,
from cell-to-cell interaction and from short range regulatory
molecules produced by the cells of the microenvironment (Dainaik
and Cohen, 1982; Dexter, 1982; Kurland et al., 1978; Sorrell and
Weiss, 1980; Tavassoli, 1975; Toksoz et al., 1980; Wagemaker,
1978; Zanjani and Kaplan, 1979).
Bone loss during space flight has been documented in
astronauts and cosmonauts (Oganov, 1981; Rambaut and Johnston,
1979; Smith et al., 1977) and rats (Jee et al., 1983; Wronsky
and Morey, 1983). ' Vacek et al. (1982) reported decreases in the
numbers of colony-forming units from tibial and femoral-marrow of
space-flown rats, formed in the spleens of rats of an isogenic
strain which were used as marrow recipients via tail vein injec-
tions. The detailed and exact histomorphometric and functional
effects of prolonged microgravity on the hematopoietic inductive
microenvironment of the bone marrow remain to be worked out;
nevertheless, some participants in this study believe that this
investigative approach holds promise for helping to define and
characterize "space anemia" and elucidating the involved biologic
mechanisms. Further, it may serve as a model for effects on other
proliferative cellular systems.
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Inhibitors of Hematopoiesis and Negative Feedback
A number of circulating hormonal and hormone-like inhibi-
tors exist whose concentrations, chemical nature, and biologic
effects could be altered by exposure to microgravity or other
environmental influences of space flight. They affect such key
processes as cell membrane transport, including that of red cell
membranes. For example, a factor that mimics the effects of
oubain on red blood cells occurs in normal cerebrospinal fluid.
It inhibits cell membrane transport causing a rise in intracellular
sodium, and, in vitro, it inhibits the activity of Na.K-ATPase
(Halperin et al., 1983).
Changes in lymphocytic activity during space flight
might induce production of a marrow-inhibiting lymphokine
(Kasahara et al., 1983). Inflight changes occur in T-lymphocytes
that impair their responsiveness to mitogenic challenge in vitro
(Taylor and Dardano, 1983). Cogoli and colleagues (1984) found
that cultures of T-lymphocytes flown in Spacelab 1 demonstrated
less than 3% activation by concanavalin A, as measured by the
incorporation of tritiated thymidine into DNA, when compared with
ground controls.
Chalones. Kivilaakso and Rytomaa (1971) described a tissue-
specific inhibitor of cell proliferation they called erythrocytic
chalone. In other studies, in vitro tests of blood from subjects
kept at strict bed rest demonstrated the appearance on the 8th
day of inhibitors of erythropoiesis (Balakhovskiy et al., 1980).
Chalones are defined as tissue-specific, species-nonspecific prod-
ucts of differentiated cells that selectively inhibit early cells
of the same lineage. In addition to suppressing erythropoiesis,
such substances have been reported to inhibit proliferation of
granulocytes; however, the existence of chalones, per se, appears
to be controversial (Cline and Golde, 1979).
A sodium transport inhibitory factor called inhibitin has
been isolated from cultured leukemic protnyelocytes (Morgan and Mir,
1984). It has demonstrated the ability to inhibit bidirectional
sodium transport in erythrocytes, apparently by reducing sodium
transport across the Na^/Na"1" exchange pathway. It does not alter
net sodium transport in erythrocytes. In addition, some experi-
mental evidence has suggested that inhibitin may be secreted by
normal promyelocytes and may have a physiologic function (Morgan
and Mir, 1984).
Natriuretic Factor. Buckalew and Gruber (1984) reviewed the
evidence that expansion of PV somehow releases a factor(s) of
low molecular weight that inhibits Na.K-ATPase systems. Numerous
studies support the hypothesis that the factor(s) is a digitalis-
like substance that inhibits Na.K-ATPase in many different
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tissues. One would expect erythrocyte membrane transport to be
influenced by such a substance, with resultant alteration of intra-
cellular sodium. However, despite a great deal of investigation,
no such substance has yet been isolated (Blaustein, 1984; Buckalew
and Gruber, 1984). A factor has been described that increases the
inhibitory effect of Ca++ on Na,K-ATPase (Yingst et al., 1984).
The substance is found in hemolysates of human red blood cells.
In in vitro tests, it markedly increases the sensitivity of Na,K-
ATPase to inhibition by Ca++; it appears to be distinct from and
independent of calmodulin. The authors emphasize its possible
physiological significance in relation to intracellular levels of
free Ca (Yingst et al., 1984).
Interferon. Another inhibitor of considerable interest is inter-
feron. Cultures of human lymphocytes flown on the Soviet Salyut-6
spacecraft reportedly produced marked increases in interferon
(Talas et al., 1983). Hooks et al. (1982) described a patient
with a proliferation of TQ cells, neutropenia, and a clinical
•diagnosis of chronic lymphocytic leukemia. Unlike normal lymphoid
cells or cells from other lymphoid neoplasms, the patient's TQ
lymphocytes spontaneously produced y-interferon in vitro. The
precise role of interferon in the pathogenesis of the patient's
blood disorder was uncertain (Hooks et al., 1982). In patients
with aplastic anemia, suppressor lymphocytes have been detected
that were shown to produce interferon and to suppress normal bone
marrow hematopoietic colony formation in vitro (Zoumbos et al.,
1985a,b). While there are no reports of the appearance of acti-
vated suppressor cells in normal subjects (Aisenberg et al.,
1981), the possibility that space flight might induce abnormal-
ities in immunocytes resulting in increased production of inter-
feron should be kept in mind. Large granular lymphocytes in
normal human blood have been shown to produce several lymphokines
including interferon (Kasahara et al., 1983; Scala et al., 1984).
Finally, a marked decline in erythrocytic glycolytic
rates, correlated with decreased plasma lactate levels and with
relaxation has been reported based on tests of arterial blood
samples taken from normal human volunteers during periods of
controlled physiologic relaxation (Jevning et al., 1983). Blood
pH, gases, glucose, and hematocrit remained within normal limits
during the 45-min experimental periods. The authors suggested
the possibility that a circulating agent induced by the prescribed
behavioral state of relaxation was involved in the observed
alteration of red blood cell metabolism.
Toxic Contaminants. Toxic substances in the breathing atmosphere
of space cabins and space suits such as intestinal gases, have
been suggested as possible factors in the loss of RCM and suppres-
sion of hematopoiesis (Tavassoli, 1982). Few reports of studies
to define the effects of mixtures of contaminants that could build
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in a space cabin atmosphere have been published (Wands, 1975). In
one study, monkeys, rats, and mice continuously exposed for 90 d
to a breathing atmosphere containing hydrogen sulfide (29 ppm),
methylmercaptan (50 ppm), indole (10.5 ppm), and skatole (3.5 ppm)
exhibited low-grade hemolysis but no signs of impaired hemato-
poiesis (Sandage, 1961). The concentrations of contaminants used
in this study were apparently selected, in part, to assure that
measurable biologic effects would result. For comparison, sug-
gested maximum air concentrations of indole, methylmercaptan, and
skatole for 90 d continuous exposure in spacecraft were 0.1 ppm
for each contaminant. For nuclear submarines, a 10-h emergency
limit of 50 ppm hydrogen sulfide was recommended (Wands, 1975).
NASA, long aware of toxic hazards in space operations,
has a toxicology program as an element of biomedical support
(Nicogossian and Parker, 1982). The environmental control and
life support systems (ECLSS) of the Space Shuttle and Spacelab
have been designed to keep trace gas contaminants at or below
acceptable levels (Rippstein, 1981). Experience in the Skylab
and Space Shuttle programs has demonstrated the capability of
properly functioning ECLSSs to maintain nonhazardous breathing
atmospheres. However, in the Shuttle Orbiter, for example, about
400 different compounds are outgassed, and estimating the poten-
tial hazard to spacecrews is extremely difficult because the
concentrations of some of the outgassed products are unknown
(Nicogossian and Parker, 1982).
While there is no evidence from American and Soviet space
flight experience that toxic contaminants in cabin atmospheres or
space suits are a source of untoward effects on hematopoiesis, such
a possibility should be considered until such time as the cause(s)
of "space anemia" has been determined.
Red Cell Sequestration; Capillary Oozing
Bone marrow suppression, by itself, has not provided a
satisfactory explanation for the initial RCM loss which occurs
within 4 d of entering orbital flight. A hypothesis that remains
viable is that, resulting from the substantial headward shift of
blood and body fluids and associated changes in regional hemody-
namics that occur early in orbital flight, changes in splenic
blood flow result in splenomegaly with entrapment of red blood
cells not normally taken up by the spleen. For example, the
physician astronaut on the Skylab 2 mission reported that spleens
were palpable. Whether sequestration necessarily results in
increased hemolysis is not known; however, direct evidence of
increased hemolysis in spacecrew members has not been reported.
The deformability of red blood cells influences their passage
through splenic sinuses, and changes in the shape of red blood
cells from some of the Skylab crew members (Kimzey, 1977) may have
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been associated with a reduction in their deformability and
possible shortening of their lifespan. However, no significant
changes in erythrocyte mean lifespan were documented in any of
the Skylab astronauts (Johnson, 1983). In addition, questions as
to whether the accelerations of launch-orbit and deorbit-reentry
might cause transient changes in capillary stress sufficient to
permit microhemorrhages should be taken into account even though
petechial or occult hemorrhages in astronauts and cosmonauts have
not been reported.
An important phenomenon in the clinical management of the
injured is the hypovolemic anemia of trauma, sometimes called the
missing blood syndrome (Valeri and Altschule, 1981). For example,
in the Korean conflict, U.S. military physicians observed substan-
tial discrepancies between estimates of blood lost in different
kinds of war wounds and the seemingly excessive amounts of blood
required to restore and maintain the RCM (Crosby and Howard, 1954).
Subsequent animal experiments demonstrated widespread subcutaneous
capillary oozing of RBC in parts of the body adjacent to and
extending from the experimental wound sites (O'Brien et al., 1957).
The RBC extravasations, while extensive, were insufficiently dense
to produce purpura or other overt signs of hemorrhage; however,
the amounts of RCM lost by this mechanism were substantial. One
of the possible mechanisms for loss of RCM in space flight might
be microhemorrhages distributed subcutaneously or elsewhere and
associated with launch-orbit and deorbit-reentry accelerations and
vibrations, or with other influences in the environment of space
flight. More information is needed on the nature of the patho-
physiologic changes that permit widespread microhemorrhaging and
whether exposure to launch and reentry accelerations, microgravity,
or other space-related factors may cause or contribute to such a
response.
Other Concepts on Etiology
While there is no experimental evidence to support the
idea, it is possible that hematopoiesis might proceed in an appar-
ently normal manner, but reticulocytes would not be released. A
difference between reticulocyte production and release implies
ineffective or impaired erythropoiesis rather than its cessation.
This phenomenon, which has been associated with pernicious anemia
and other megaloblastic anemias, may be another possible variable
in assessing erythrokinetics in weightlessness. When large differ-
ences in bone marrow activities occur, changes in corrected reticu-
locyte counts are a relatively good measure (Crosby, 1981). But
during space flight, relatively small sustained changes in red cell
production lead to RCM losses of about 10%. Such changes may be
difficult to interpret unless careful attention is paid to collec-
tion of data before, during, and after space flights, as well as
critical attention to proper correction of reticulocyte count
data. Furthermore, it is obvious that weightlessness is not
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the most ideal experimental situation in which to make repeated
blood collections. In addition, even if possible, data on reticu-
locyte counts are an incomplete reflection of all biological
activities of the bone marrow.
Postflight studies of the Skylab astronauts demonstrated
no prolongation of iron clearance (Johnson, 1983), and, infor-
mation presented at the ad hoc Working Group meeting indicated
that Spacelab 1 inflight studies showed iron turnover proceeding
normally. These findings do not seem to support a concept of
total marrow inhibition during space flight. The hematopoietic
responsiveness of the bone marrow in the presence of negative
nitrogen balance was discussed. Some participants were of the
opinion that hematopoiesis ceases in such circumstances. Whether
the degree of negative nitrogen balance observed in Skylab would
so affect the marrow is unknown.
Reduced barometric pressure, or hypobaria, was an impinging
environmental factor in all United States manned programs through
Skylab. In the Shuttle program, exposure to hypobaria is limited
to EVA in the space suit, representing a transient experience of
part of the Shuttle crew. Johnson (1983) listed hypobaria as a
possible contributor to the loss of RCM.
A great deal of research has been done on factors that
cause changes in the deformability of red blood cells in vitro and
relationships between stiffening of the RBC membrane and suscepti-
bility to sequestration and hemolysis. However, little is known
about the influence of such factors in vivo. Thus, basic studies
of the effects on RBC deformability of such factors as increased
prostaglandin £2 production in the spleen, alterations of intra-
cellular calcium levels, and metabolic depletion of intracellular
ATP concentrations in animal models of hypodynamia/hypokinesia
might yield data of value in defining basic or contributing
mechanisms. Very little is known about the Influence of micro-
gravity on blood circulation in bone marrow except that the
effects, if any, appear to be reversible eventually when 1-G
gravitational force is restored.
Other Questions and Points of Emphasis
Whether the epo produced inflight retains its normal
erythropoietic function is an important question. Results of
the bioassays of epo done on inflight samples of blood from the
Spacelab 1 mission suggest that epo levels were not significantly
altered; however, data are not available to determine the func-
tional status of epo during space flights (Leach and Johnson,
1984). Another question for which more data are needed is whether
erythropoietic bone marrow that has been exposed to space flight
responds normally to its trophic hormone. The work of Vacek
et al. (1982) suggests that marrow from space-flown rats is less
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hematopoietically responsive than marrow from ground control
animals. In addition, Kozinets et al. (1983) reported that,
in space-flown rats, bone marrow cell distribution shifted toward
enhanced myelopoiesis and diminished erythropoiesis. Future plans
should include acquisition and preservation of marrow samples
during space flight as well as the use of samples obtained post-
flight.
During the months-long space flights, such as in the
Salyut-6-Soyuz program, some erythropoiesis must take place
as reductions in RCM do reach a stable plateau and continued
decreases do not occur. The question whether erythrocytes pro-
duced during long space flight are functionally normal deserves
careful scrutiny. During the readaptation periods following
missions lasting 96-, 140-, and 175-d, Soviet scientists reported
marked reduction of erythrocytic half-lives in a time when .pro-
duction of reticulocytes increased to approximately 238% of base-
line (Ilyukhin and Buvkovskaya, 1981). The authors suggested that
the erythrocytes produced under such circumstances were function-
ally defective and had a shorter lifespan. Additional data on
erythropoiesis and red cell functions during prolonged space
flights are needed.
Inasmuch as in-depth review of certain topics was beyond
the resources of the present study, NASA authorities may find it
expedient to commission reviews of selected topics. Examples
might include: (1) the role of calcium, parathormone, and other
hormones on bone marrow function, for which a number of papers
exist in the endocrinologic literature; (2) mechanisms and regula-
tion of the intracellular utilization of oxygen; (3) a comprehen-
sive review of all hormones and hormone-like substances that
influence hematopoiesis and their effect on total body oxygen
consumption; and, (4) an estimate of the hematologic effects of
exposure to space radiations in the range of dosages estimated
for 90-d space station occupancy (e.g., 15-20 rem) and on a Mars
expedition (e.g., 200 rem in a 1-y trip to Mars). Of special
interest is the question of the hematopoietic effects of exposure
to the heavy nuclear component of space radiations.
The subject of the possible hematologic effects of the
nonspecific stresses of space flight was discussed. In laboratory
animals, stresses associated with experimentation such as handling
and restraint can cause major homeostatic disruptions including
effects on hematopoiesis (Burton et al., 1981; Dunn et al.,
1985a,b). Hematologic parameters in astronaut blood samples
taken a day or so before a mission may differ markedly from those
in samples taken 30 or 60 d before flight. However, most partici-
pants considered it unlikely that nonspecific stresses of space
flight constitute a significant factor in the loss of RCM.
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B. METHODOLOGY AND MODELS
The members of the ad hoc Working Group offered a number
of suggestions on methodology and models. For some blood param-
eters, limitations of methodology have hampered acquisition of
highly reliable data. Two prominent examples are the bioassay
used for epo estimation in Spacelab 1 and certain features of the
method used for counting reticulocytes. As is recognized by NASA
scientists, the currently preferred method for epo assay is the
radioiramunoassay (RIA) introduced by Garcia and Goldwasser (Garcia
et al., 1979). While it is true that supplies of purified epo for
the RIA have been severely limited, it is anticipated that ample
supplies will soon be available.
Reticulocyte counts provide part of the necessary data
base for analyzing factors involved in the loss of RCM. There is
a need for improved means of counting reticulocytes quickly and
accurately (Crosby, 1981). Automated methods such as flow cytom-
etry and automated differential counting have not yet evolved to
the desired level of accuracy, but their development should be
supported. Meanwhile, NASA should probably rely on the 2,000 cell
count, which is "standard" in contemporary hematology.
Acquiring, treating, storing, and analyzing blood specimens
inflight need innovative methodology to facilitate and improve the
accuracy of determinations of such parameters as hemoglobin, arter-
ial hemoglobin .PSQ, erythrocytic ATP, 2,3-DPG, intracellular sodium,
and PC02« For meaningful estimates of ATP and 2,3-DPG, means
should be developed for prompt acid precipitation of RBC proteins
in freshly obtained samples inflight. Some members of the Working
Group have found the Hemoscan* machine to be a useful aid for P^Q
determinations. An inflight method of precise separation of RBC
and plasma is needed for preparation of samples for accurate bio-
chemical analysis.
The influence of changes in lean body mass on interpre-
tation of RCM estimates should be examined because of a possibility
that losses of RCM could be greater than suggested by the highly
accurate 5*Cr technique. For example, Nathan (1966) presented
some relationships among body weight, body habitus, total body
water, total exchangeable potassium, and the interpretation of
total red cell volume measurements. His data showed that the
simple ratio of total red cell volume to body weight was unreli-
able, being low in obese subjects and high in lean individuals.
For exploring the effects of actual and simulated space
flight on the erythropoietic organ in situ, a useful approach
involves models developed by Tavassoli, Crosby, and others. For
example, it is possible to observe simultaneous repair and replace-
ment of marrow and bone at the same site following mechanical
injury. The method has been sufficiently standardized to allow
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quantitative estimates of proliferation of hematopoietic and
stromal cell lines of marrow in extramedullary sites. The sched-
ule of cellular development in this model is suitable for use in
the Shuttle program (Sahebekhtiari and Tavassoli, 1978; Tavassoli
and Crosby, 1968, 1970). Models of osteogenesis and hematopoiesis
developed by McCarthy, Huggins, and others should also be consid-
ered (Lambertsen and Weiss, 1984; McCarthy et al., 1984; Reddi and
Huggins, 1972).
The rat has been used more extensively than other labora-
tory animals for studies of space-related hematologic responses.
Whether it is the most suitable experimental animal for such
investigations has not been established. Dunn et al. (1984b)
compared the hematologic effects of ground-based simulation of
microgravity in human subjects, rats, and squirrel monkeys with
known responses in space flight. The authors concluded that all
three models simulate one or more of the factors involved in
"space anemia," but responses varied with the species and experi-
mental techniques. More recently, Dunn et al. (1985a,b) reported
that most of the effects on erythropoiesis of using the rat model
in the antiorthostatic, hypokinesic and hypodynamic mode (e.g.,
Morey-Holton and Wronsky, 1981; Musacchia et al., 1980), can be
explained in terms of the physical restraint rather than the
antiorthostatic position resulting from head-down suspension.
Only changes in survival of red blood cells were considered unique
to the head-down posture. Similarly, while the results from
inflight studies of rats (Leon et al., 1978, 1980) are important,
several related questions remain to be addressed. For example, in
the Cosmos experiments, animals were free-floating in the cages.
Because the proprioceptors of the rat are so exquisitely sensitive
to balance and position, it would be useful to compare experimen-
tally (in weightlessness) centrifuged rats with those which could
only "stand" on the floor or ceiling of the cage.
It is noted that one of the objectives of the rat experi-
ments programmed for Spacelab 4(SLS-1) is to obtain more data by
which to determine the suitability of the rat as an experimental
model for hematologic studies. Because certain hematologic
responses in rats have been shown to be age- and sex-dependent
(Shvets et al., 1984), it is suggested that mature females offer
greater hematologic stability than young growing animals and
males, whose growth is continuous. All participants in the LSRO
study concurred in the need for continuing the quest for suitable
laboratory animal models for ground-based and inflight investiga-
tions.
Finally, some members of the Working Group consider
it essential for proper experimental control of inflight animal
studies to equip space laboratories with a small animal centrifuge
to simulate Earth gravity.
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C. CONCLUSIONS
Despite substantial investigation in the United States
and Soviet Union, the etiology and biologic mechanisms responsible
for loss of RCM during space flight have not been adequately
defined. A majority of the experts consulted by LSRO consider it
to be one end point of the processes of physiologic adaptation to
weightlessness; hence, the primary cause is probably the influence
of microgravity itself. However, because of expert opinion that
other factors may contribute to the altered erythrokinetics, the
research suggestions in Chapter V embrace additional elements of
space flight such as the accelerations of launch and reentry and
the metabolic disturbances of the musculoskeletal systems.
While the loss of RCM has apparently been clinically
insignificant, the members of the Working Group consider it a
potentially adverse response that may require control in some
postulated circumstances such as inflight illness or injury,
malfunction of life support systems, repeated space flights
without full interval recovery, and future, very long space
missions. Moreover, it is a highly significant, reproducible
biological response to space flight.
The evidence from inflight experiments firmly indicates
that weightlessness is the prime cause of increased random hemol-
ysis in rats. However, the participants in this study considered
that, while microgravity is apparently the key etiologic factor,
other factors probably contribute. Therefore, a number of possi-
ble ancillary elements of. space flight are treated in the report.
Because of the obscurity of the involved biologic mechanisms and
the limitations of the available data base, the members of the
Working Group included some speculation with their discussions of
possible basic and contributory mechanisms. Their concepts and
suggestions on possible etiologic and mechanistic factors are
outlined in Chapter IV and treated as research suggestions in
Chapter V. The ad hoc Working Group concluded that more, extensive
data obtained under controlled conditions would be necessary to
evaluate the existing hypotheses or to formulate new theories on
RCM loss.
At present, NASA's formal research program on the effects
of space flight on erythrokinetics consists mainly of preparations
for inflight studies in the SLS-1, including flight tests on other
Shuttle missions of animal holding facilities for SLS-1. Postflight
specimens of blood, bone marrow, and other tissues from animals
flown in the flight tests will afford some opportunities for
follow-up studies.
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A majority of the members of the ad hoc Working Group
concluded that the loss of RCM in space flight and the delays in
postflight recovery should be of much more than academic interest
to NASA. As is reflected in the list of research suggestions,
future plans should provide for a sustained ground-based and
flight research program aimed toward gaining a clear definition
of the etiology, involved mechanisms, and, if necessary, means of
intervention.
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V. SUGGESTIONS FOR RESEARCH EMPHASIS
In the opinion of the Working Group, a lack of sufficient
data on several important hematological parameters underscores the
need to expand the data base by all feasible means including ground-
based laboratory studies, space flight simulations, and investi-
gations during space flight. Table 4 lists items that should be
considered for expanding the data base; they should be measured not
only in formally programmed specific research, but also as parts of
routine biomedical assessments and informal ground and space flight
experiments and tests.
The following suggestions for research and methodology are
presented without reference to priority except that basic research
topics are listed first. Inflight experiments are preceded by
corresponding ground-based studies wherever feasible, and methodo-
logic suggestions are presented last.
t
Basic and Applied Studies
• Based on the evidence that the oxygen sensor for regula-
tion of epo production is located in the kidney, the rela-
tionships among such factors as renal oxygen consumption,
renal sodium reabsorption, glomerular filtration, and
erythrocytosis should be investigated. In the kidney,
oxygen consumption is primarily determined by sodium
reabsorption which, in turn, depends on glomerular filtra-
tion and blood flow. Measurement of renin production
should be included. Approaches to consider include ground-
based experiments with animals made erythrocytotic by
transfusions, patients with polycythemia, and spacecrew
members inflight.
• Bone marrow function in situ as influenced bjr simulated
and actual weightlessness should be examined. For example,
in ground-based experiments with animal and human subjects,
relationships among erythropoiesis, bone demineralization,
calcium and phosphorus mobilization, and negative calcium
balance should be investigated. Inflight extensions
should be planned if results so indicate. In addition to
the examples of experimental models that are mentioned in
the section on Methodology, research approaches should
include, when feasible, examination of bone marrow
biopsies as distinguished from bone marrow smears.
• Ground-based animal experiments should be devised to
detect possible excessive hemolysis, sequestration by
the spleen or other organs and tissues, and capillary
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Table 4. Baseline Data for Analysis of Erythrokinetics of Space Flight*
Parameter Settings and Subjects
Ground-basedt Inflight§
Animal Human Animal Human
Red cell count •»• + + +
Hemoglobin + + + +
Hematocrit • » • • * • • » • +
Red cell mass + + •»• +
Blood volume + + + +
Plasma volume * + + •»•
Reticulocyte count + + + +
Erythropoietin + + + •»•
Plasma or serum haptoglobin + + + +
Platelets + +• + *
Red cell shape + + + +
Red cell size + + +• +
Blood ? 5 Q • » • • « • • » • +
Blood PC02 * + * +
Red cell 2,3-DPG + + -t- +
Red cell ATP + * + +
Red cell sodium + +• + +
Skin petechiae - + +
Subcutaneous, subserosal
oozing of RBC - +
Bone marrow smear + +•
* When feasible, measure sequentially for temporal aspects.
tExamples: biological laboratories, hospitals, space simulation facilities
(bed rest, water immersion, etc.), spacecraft simulators.
§ Include pre-, in-, and postflight phases.
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oozing of red blood cells induced by the typical acceler-
ation profiles of Shuttle flights. If positive findings
occur, inflight extensions of such studies should be
planned.
Certain recently developed hematologic methods may be
able to detect subtle or subclinical changes in blood and
hormonal parameters that may be associated with the loss
of RCM. In view of NASA's standing operating procedures
for prebreathing 100% oxygen prior to EVA's, the possible
subtle hematologic effects of such exposures to hyperoxia
should be reconsidered.
A number of circulating, hormone-like inhibitors exist
that can influence cellular function such as natriuretic
factor and a factor from normal cerebrospinal fluid that
inhibits membrane transport including red cell membrane
transport. The inhibition can lead to an increase of
intracellular sodium and cell volume.. Certain hypo-
metabolic states have been associated with a marked
diminution of lactate production by erythrocytes. A
transport factor called "inhibitin", derived from leukemic
promyelocytes, affects red cell production, involving a
different set of transport mechanisms than does natri-
uretic factor. Consideration should be given to support
additional studies to (1) identify and characterize
possible circulating biochemical inhibitors of cell
function and erythropoeisis and (2) determine possible
changes in their concentrations and characteristics in
blood from subjects who have been exposed to microgravity.
Bone metabolism and its hormonal control in simulated
and actual weightlessness should be examined in relation
to effects on erythropoiesis. There is a need for more
knowledge of blood-bone relationships.
Proposals should be solicited for studies of the cellular
and molecular regulatory mechanisms that affect utili-
zation of epo in the erythropoietic process. This might
lead to discovery of cellular or subcellular receptors or
responses that influence RCM.
Inflight changes in erythrocyte intracellular sodium
could influence the vulnerability of RBC to destruction.
Inflight specimens of red blood cells carefully separated
from plasma should be stored for postflight analysis of
sodium content. (See also, Methodology).
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• A gradual and continuing urinary loss of sodium has
been documented in both U.S. and Soviet space missions.
The influence of changes in concentrations of the sodium
carbonate anion in blood on red cell metabolism should be
addressed.
• In view of the stability of epo and the availability of
the radioimraunoassay for its accurate determination, a
reexamination of stored blood from prior NASA missions
would be of interest for comparative purposes and to add
to the data base.
• The question whether exposure to microgravity may alter
the physical and biochemical nature of epo should be
addressed by performing functional assays of epo from
space-flown subjects.
• Research proposals should be solicited to answer such key
questions about "astronaut anemia" as: "Why does recovery
take at least 30 days? Is it significant that recovery
periods are analogous to those seen in subjects who give
blood or undergo phlebotomy?" Related aspects include epo
production and circulating epo levels, other endocrine
changes, and marrow cell changes during the postflight
recovery period.
• Studies of concentrations of colony-forming cells in the
spleens (of irradiated mice) and erythroid, as well as
granulocyte-macrophage precursors in cultures of blood
from space-flown experimental animals and spacecrew
members and from bone marrow and spleens of space-flown
animals, should be scheduled as routine procedures to
establish a suitable data base. In addition, the integ-
rity of marrow stroma should be studied in long-term
tissue cultures.
• The question whether circulating interferon levels nay be
altered in space flight should be considered in view of
the depressant effect of interferon on cell proliferation.
One approach would be to examine smears of blood from
subjects exposed to microgravity for lymphocytes contain-
ing large secretory granules such as those that character-
ize TQ-cell lymphoproliferative disorders. Another
approach might be measurement of activation of suppressor
cells using monoclonal antibodies. Such studies should
include pre-, in-, and postflight observations.
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• Some members of the Working Group suggested that nutri-
tional factors should be studied as one approach toward
resolving the etiology of decreased RCM. At a minimum,
an accurate record of food and fluid intake by each member
of a space crew throughout a mission seems essential. For
this, a recording system should be developed that is as
nearly automatic as possible and free from interference
with duties or potential for distraction or nuisance.
Plans should include provision for measuring plasma
proteins and plasma and urinary amino acids of spacecrew
members whenever feasible.
• Carefully designed metabolic balance studies of members of
Shuttle crews should be considered as a means of expanding
the data base on inflight nitrogen and calcium metabolism.
It might be feasible to do this periodically with single
volunteer crew members and a modified Skylab-type meta-
bolic protocol in order to keep disruptions associated
with such studies at a minimum.
• Some evidence suggests that the more physically fit
astronauts experience the greatest drop in RCM during
space flight. This, and the parallel phenomenon of
diminished acceleration tolerance in physically trained
versus sedentary subjects who have been exposed to periods
of hypodynamia should be examined.
Methodology
For epo determinations, the radioimmunoassay should be
used. While it is true that supplies of pure epo for
the RIA have been limited, it is anticipated that ample
amounts will soon be available.
Participants acknowledged the inadequacies of available
methods of counting reticulocytes and concurred in a need
for a better method. The "standard" count in contemporary
hematology is 2,000 cells. The flow cytometric methods
offer the possibility of semi-automation; their further
development should be supported.
Inflight methods should be developed for key hematologic
measurements such as (1) hemoglobin, red cell volume, and
sodium content; (2) prompt acid precipitation of RBC
proteins in blood samples for use in determining ATP and
2,3-DPG of erythrocytes; and, (3) preparation and handling
of blood samples for determination of P$Q and PCC-2 values.
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Use of models of hemopoiesis in appropriate experiments,
such as those developed by Tavassoli, Crosby, and others
(Sahebekhtiari and Tavassoli, 1978; Tavassoli and Crosby,
1968, 1970) and by McCarthy, Reddi, Huggins, and others
(Lambertsen and Weiss, 1984; McCarthy et al., 1984; Reddi
and Huggins, 1972) should be explored.
There is a need for a method for precisely separating RBC
from plasma inflight for postflight biochemical analyses.
While the rat has been the primary animal model for
studies of hematologic effects of space flight, it may
prove to have limited usefulness for certain types of
experiments (Dunn et al., 1985a,b). Efforts to identify
and "standardize" alternate animal models should be
continued.
The repeated, sequential measurement of changes in certain
blood parameters such as RCM and epo is essential for
defining the time course of inflight changes. When
possible, experimental protocols should be designed
accordingly.
The concept that space-related loss of RCM may be asso-
ciated with physiologic adaptation to reduced energy
demands in weightlessness suggests a need for more compre-
hensive knowledge of total metabolic expenditures of
spacecrew in representative patterns of inflight activity.
For example, development of technology to support such
studies in real time in the space station should be given
strong backing.
Some investigators have observed marked variation in blood
parameters from samples drawn one day before launch com-
pared with samples taken several weeks previously. A
study should be planned to determine the best time to take
blood for baseline data during the last few days before a
mission.
In view of the fact that iron clearance occurs in a matter
of hours, the Working Group endorses the need for iron
turnover studies, including injection of the radiolabeled
iron, to be performed inflight.
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